; Juniper Pharmaceuticals | Press Releases

Press Releases

2017 | 2016 | 2015 | 2014 | 2013

Juniper Pharmaceuticals Presents Poster at SMFM 2017 on Current Practice Among U.S. Obstetricians to Screen, Define, and Treat a Short Cervix to Prevent Preterm Birth

Physician Survey Demonstrates Need for an Approved Vaginal Progesterone Product Juniper is Advancing Its Investigational Progesterone Intravaginal Ring to Treat Women at Risk for Preterm Birth due to Short Cervix BOSTON, Jan. 26, 2017 /PRNewswire/ -- Juniper Pharmaceuticals (Nasdaq: JNP) ("J...

Read More

Juniper Pharmaceuticals Unveils Strategic and Product Development Objectives for 2017

Juniper Advancing IVR Pipeline while Actively Pursuing Partnering Opportunities Aligned with Mission to Transform Women's Health BOSTON, Jan. 6, 2017 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company") today announced plans for 2017 that are expected to enab...

Read More

Juniper Pharmaceuticals Announces Poster Presentation at Society for Maternal-Fetal Medicine 2017 Annual Meeting

BOSTON, Jan. 5, 2017 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), a women's health therapeutics company, today announced that an abstract describing data exploring current practices among U.S. obstetricians to screen, define, and treat a short cervix...

Read More